Published in Can Med Assoc J on June 09, 1979
The treatment of depressive states with G 22355 (imipramine hydrochloride). Am J Psychiatry (1958) 3.18
CLINICAL PHARMACOLOGY OF IMIPRAMINE AND RELATED ANTIDEPRESSANT COMPOUNDS. Pharmacol Rev (1965) 2.01
A cholinergic-adrenergic hypothesis of mania and depression. Lancet (1972) 1.97
A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosom Med (1975) 1.68
INHIBITION OF NORADRENALINE UPTAKE BY DRUGS. J Pharm Pharmacol (1965) 1.67
Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. Eur J Pharmacol (1967) 1.57
Clinical consequences of polymorphic acetylation of basic drugs. Clin Pharmacol Ther (1977) 1.50
Antidepressants and the muscarinic acetylcholine receptor. Arch Gen Psychiatry (1977) 1.49
Cardiac antiarrhythmic effect of imipramine hydrochloride. N Engl J Med (1977) 1.47
Impairment of drug metabolism in man by allopurinol and nortriptyline. N Engl J Med (1970) 1.44
Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs. J Pharmacol Exp Ther (1970) 1.26
Plasma nortriptyline levels--relationship to clinical effects. Clin Pharmacol Ther (1974) 1.21
Physostigmine. Its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. Arch Gen Psychiatry (1975) 1.20
Clinical pharmacology of phenelzine. Arch Gen Psychiatry (1978) 1.19
VASCULAR CRISES ASSOCIATED WITH MONOAMINE-OXIDASE INHIBITORS. Am J Psychiatry (1964) 1.17
Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Arch Gen Psychiatry (1975) 1.17
Clinical implications of imipramine plasma levels for depressive illness. Arch Gen Psychiatry (1977) 1.12
Interaction between clonidine and desipramine in man. Br Med J (1973) 1.11
Nortriptyline plasma levels and therapeutic response. Clin Pharmacol Ther (1976) 1.04
Drug excretion in breast milk. Postgrad Med (1974) 1.02
Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine. JAMA (1977) 1.00
First-pass metabolism of imipramine in man. Clin Pharmacol Ther (1975) 0.97
Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slices. J Pharm Pharmacol (1970) 0.95
Amitriptyline plasma levels and clinical response in primary depression. Clin Pharmacol Ther (1977) 0.95
A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness. Psychopharmacology (Berl) (1979) 0.95
Metabolism of tricyclic antidepressants. A review. Dan Med Bull (1974) 0.94
Toxicity of hydrazine derivatives of isonicotinic acid in the chemotherapy of human tuberculosis; a preliminary report. Q Bull Sea View Hosp (1952) 0.91
Acetylation phenotype, platelet monoamine oxidase inhibition, and the effectiveness of phenelzine in depression. Am J Psychiatry (1978) 0.81
The clinical effect of isoniazid and iproniazid in the treatment of pulmonary tuberculosis. Ann Intern Med (1954) 0.80
The use of bethanechol chloride with tricyclic antidepressants. Am J Psychiatry (1975) 0.80
Benzodiazepines and tricyclic antidepressant plasma levels. Br Med J (1973) 0.80
Plasma concentrations of protriptyline and clinical effects in depressed women. Br J Psychiatry (1976) 0.79
Blockade by psychotropic drugs of the muscarinic acetylcholine receptor in cultured nerve cells. Biol Psychiatry (1977) 0.79
Metabolism of 14C-imipramine. I. Excretion in the rat and in man. Psychopharmacologia (1968) 0.77
Indications for specific treatments of depressions. Psychopharmacol Bull (1975) 0.77
Protriptyline kinetics. Clin Pharmacol Ther (1978) 0.77
Combining tricyclic and monoamine oxidase inhibitor antidepressants. Arch Gen Psychiatry (1976) 0.77
Agranulocytosis associated with tricyclics. J Clin Psychiatry (1978) 0.76
Enhancement of propoxyphene-induced analgesia by doxepin. Psychopharmacology (Berl) (1977) 0.76
Pharmacokinetic aspects of protriptyline plasma levels. Eur J Clin Pharmacol (1977) 0.76
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med (2000) 10.25
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA (1998) 4.48
Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiatry (1989) 3.32
The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther (2000) 3.07
Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry (2000) 2.70
The catatonic syndrome. Lancet (1976) 1.82
Risk-benefit decision making for treatment of depression during pregnancy. Am J Psychiatry (2000) 1.61
Gender differences in chronic major and double depression. J Affect Disord (2000) 1.53
A review of 32 cases of tardive dystonia. Am J Psychiatry (1991) 1.45
Serum lithium levels and psychosocial function in patients with bipolar I disorder. Am J Psychiatry (1996) 1.42
Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. Arch Gen Psychiatry (1992) 1.40
Lost human capital from early-onset chronic depression. Am J Psychiatry (2000) 1.25
Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. J Clin Psychiatry (1989) 1.23
Lecithin can suppress tardive dyskinesia. N Engl J Med (1978) 1.14
Pharmacologic treatment of depression during pregnancy. JAMA (1999) 1.12
Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression. Acta Psychiatr Scand (2006) 1.10
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. J Clin Psychiatry (1998) 1.05
Citalopram as adjunctive therapy in bipolar depression. J Clin Psychiatry (2001) 1.02
Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry (1979) 0.97
Monoamines and the mechanism of antidepressant action: effects of catecholamine depletion on mood of patients treated with antidepressants. Psychopharmacol Bull (1993) 0.96
Catatonic reactions to high-potency neuroleptic drugs. Arch Gen Psychiatry (1977) 0.96
A placebo-controlled multicenter trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness. Psychopharmacology (Berl) (1979) 0.95
Tryptophan depletion and depressive vulnerability. Biol Psychiatry (1999) 0.93
Sertraline versus imipramine to prevent relapse in chronic depression. J Affect Disord (2001) 0.92
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. J Clin Psychiatry (1998) 0.90
Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry (1982) 0.90
Munchausen's syndrome with a psychiatric presentation. Dis Nerv Syst (1977) 0.88
Pregnancy, psychotropic drugs, and psychiatric disorders. Psychosomatics (1986) 0.85
Diltiazem for tardive dyskinesia and tardive dystonia. Lancet (1988) 0.84
Amoxapine--an antidepressant with some neuroleptic properties? A review of its chemistry, animal pharmacology and toxicology, human pharmacology, and clinical efficacy. Pharmacotherapy (1986) 0.84
Clozapine versus chlorpromazine for the treatment of schizophrenia: preliminary results from a double-blind study. J Clin Psychiatry (1979) 0.84
Treating extrapyramidal reactions: some current issues. J Clin Psychiatry (1987) 0.83
Prevalence of tardive dyskinesia in an outpatient population. Compr Psychiatry (1980) 0.82
The amobarbital interview. Mil Med (1980) 0.82
Pindolol augmentation of treatment-resistant depressed patients. J Clin Psychiatry (1997) 0.82
Serum lithium levels and the outcome of maintenance therapy of bipolar disorder. Bipolar Disord (2000) 0.82
Neurotransmitter precursors for the treatment of depression. Psychopharmacol Bull (1982) 0.81
Sexual dysfunction secondary to depressive disorders. J Gend Specif Med (2001) 0.80
Double-blind comparison of amoxapine and imipramine in the treatment of depressed patients. J Clin Psychiatry (1984) 0.80
Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients. Psychopharmacology (Berl) (1992) 0.79
Choline and lecithin administration to patients with tardive dyskinesia. Trans Am Neurol Assoc (1978) 0.79
Tyrosine for the treatment of depression. Am J Psychiatry (1980) 0.79
L-tyrosine in depression. Lancet (1980) 0.78
Bipolar disorder in women: reproductive events and treatment considerations. Acta Psychiatr Scand (2005) 0.78
Effects of two antidepressants on memory performance in depressed outpatients: a double-blind study. Psychopharmacology (Berl) (1984) 0.78
Criteria for the diagnosis of catatonia. Am J Psychiatry (1977) 0.78
The effect of dantrolene sodium on spasticity in multiple sclerosis. Neurology (1973) 0.78
Computerized tomography in patients with tardive dyskinesia. Am J Psychiatry (1976) 0.77
Renal function monitoring in patients receiving lithium carbonate. J Clin Psychiatry (1981) 0.77
Effects of lithium on the kidney. Acta Psychiatr Scand (1987) 0.77
The pharmacologic treatment of schizophrenia: a progress report. Schizophr Bull (1983) 0.76
Alpha 2-adrenergic receptors in platelet membranes of depressed patients: increased affinity for 3H-yohimbine. Psychiatry Res (1987) 0.76
Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate. Am J Psychiatry (1979) 0.76
Tyrosine for the treatment of depression. Nutr Health (1984) 0.76
Unusual lymphocyte subset distribution in some depressed patients. J Clin Psychiatry (1990) 0.76
General principles of treatment of extrapyramidal syndromes. Clin Neuropharmacol (1983) 0.76
Open-label sildenafil treatment of partial and non-responders to double-blind treatment in men with antidepressant-associated sexual dysfunction. Int J Impot Res (2006) 0.75
Editorial statement. Acta Psychiatr Scand (1995) 0.75
Major complications of neuroleptic drug use. West J Med (1994) 0.75
The effect of amoxapine and imipramine on serum prolactin levels. Arch Intern Med (1981) 0.75
Nutrition in psychiatry: we are what we eat? J Clin Psychiatry (1980) 0.75
Depression, depressants, and antidepressants. Arch Intern Med (1990) 0.75
Single case study. Amoxapine, a new antidepressant, appears in human milk. J Nerv Ment Dis (1979) 0.75
Knowing our limits. Acta Psychiatr Scand (1998) 0.75
Alpha 2-adrenergic receptor sensitivity in depressed patients: relation between 3H-yohimbine binding to platelet membranes and clonidine-induced hypotension. Biol Psychiatry (1989) 0.75
A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients. J Clin Psychopharmacol (1985) 0.75
Chemistry, pharmacology, pharmacokinetics, adverse effects, and efficacy of the antidepressant maprotiline hydrochloride. Pharmacotherapy (1986) 0.75
Psychiatry in the 1990s. J Clin Psychiatry (1991) 0.75
Treatment of bipolar disorder: how far have we come? Psychopharmacol Bull (1994) 0.75
Psychiatry as a medical specialty. Am J Psychiatry (1972) 0.75
The effects of amitriptyline and lithium on a patient with 48-hour recurrent depressions. J Nerv Ment Dis (1978) 0.75
Psychiatry 2013. J Clin Psychiatry (1993) 0.75
Fluoxetine and sexual dysfunction. JAMA (1995) 0.75
Verapamil treatment of acute mania. J Clin Psychiatry (1986) 0.75
Hazards and adverse effects of lithium. Annu Rev Med (1982) 0.75
New antidepressant drugs: a clinical perspective. Psychopharmacol Bull (1984) 0.75
Pharmacologic treatment of depressive subtypes. Psychiatr Med (1988) 0.75
Recurrent unipolar depressions with a 48-hour cycle: report of a case. Br J Psychiatry (1978) 0.75
Psychotherapy in severe depression: hypothesis-generating versus hypothesis-testing. J Clin Psychiatry (1979) 0.75
Conclusion on convulsions. Psychosomatics (1985) 0.75
Cardiac arrhythmias after psychotropic drugs. Am J Cardiol (1977) 0.75
Letter: Grams of antipsychotics? N Engl J Med (1976) 0.75
Threats and promises. J Clin Psychiatry (1995) 0.75
Tryptophan and 5-HT in psychiatric illness. Adv Exp Med Biol (1996) 0.75
Antidepressants: their use in clinical practice. Ration Drug Ther (1978) 0.75
Ergoloid mesylates and ECT. J Clin Psychiatry (1989) 0.75
Treating the outpatient schizophrenic. Postgrad Med (1978) 0.75
Tardive dyskinesia and lithium-associated nephropathy: are you liable? J Clin Psychiatry (1980) 0.75
Choline and lecithin for the treatment of tardive dyskinesia [proceedings]. Psychopharmacol Bull (1979) 0.75
Imperfect drugs in an imperfect world. J Clin Psychiatry (1992) 0.75
Enhancement of ECT benefit by yohimbine. J Clin Psychiatry (1986) 0.75
Using physostigmine safely. Am J Psychiatry (1979) 0.75
Anticholinergic effects on memory: benztropine vs. amantadine. Psychopharmacol Bull (1987) 0.75
Use of choline and lecithin in the treatment of tardive dyskinesia. Adv Biochem Psychopharmacol (1980) 0.75
Tyrosine for depression. J Psychiatr Res (1984) 0.75
Galactorrhea and hyperprolactinemia associated with amoxapine therapy. Report of a case. JAMA (1979) 0.75
Use and abuse of anticholinergic drugs in psychiatry. Hillside J Clin Psychiatry (1984) 0.75
If not now, when? J Clin Psychiatry (1992) 0.75
Consent and liability with neuroleptics: the problem of tardive dyskinesia. Int J Law Psychiatry (1986) 0.75
Amoxapine for the treatment of psychotically depressed subjects. A pilot study. J Nerv Ment Dis (1985) 0.75